IBSA Germany

What IBSA Germany does

IBSA Germany, legally IBSA Pharma GmbH, is the Düsseldorf-based German operating subsidiary of IBSA Group (Institut Biochimique SA), a Swiss multinational pharmaceutical company founded in 1945 in Lugano. The entity is located at Königsallee 14, 40212 Düsseldorf, and functions as one of 20 direct commercial subsidiaries within the IBSA Group network that collectively distributes pharmaceutical products across more than 90 countries on 5 continents.

The company's commercial offering spans 10 therapy areas: reproductive medicine, endocrinology, pain and inflammation, osteoarticular medicine (bone and joint), aesthetic medicine, uro-gynecology, dermatology, cardiometabolic medicine, respiratory, and consumer health. Underlying technology is described as pharmaceutical formulation and drug delivery across these therapy areas, with no disclosed patents, proprietary software platforms, or technology partnerships in the input data. The German website lists six therapy areas prominently on its navigation (reproductive medicine, endocrinology, pain/inflammation, bone and joint, aesthetic medicine, uro-gynecology), with the broader 10-therapy portfolio positioned at the group level.

IBSA Germany operates as a private GmbH under a strategic parent (IBSA Group) and employs approximately 25 people locally, against the parent's global workforce of more than 2,500. The go-to-market motion is enterprise field sales through the parent's subsidiary network, with revenue derived from pharmaceutical product sales. Pricing is not publicly disclosed and is presumably negotiated through German healthcare system, insurance, and institutional procurement channels. The entity has no disclosed funding rounds, no M&A activity, no leadership changes, and no competitive moat information beyond the parent group's Swiss regulatory heritage, established 80-year brand, and controlled distribution footprint. Strategic positioning emphasizes four pillars — Human Focus, Innovation, Quality, and Responsibility — alongside ESG-linked initiatives such as the IBSA Foundation and IBSA Sailing.

Name

IBSA Germany

Legal name

IBSA Pharma GmbH

Website

https://ibsa-pharma.de

Company type

Private

Founded year

1945

Operating status

Operating

Headcount range

11–50 employees

Short description

IBSA Germany (IBSA Pharma GmbH) is the Düsseldorf-based German subsidiary of Swiss pharmaceutical group IBSA, commercializing a diversified portfolio across 10 therapy areas including reproductive medicine, endocrinology, aesthetic medicine, and consumer health via direct subsidiary sales.

Ownership category

akta.pro rank

Headquarters

HQ city

Düsseldorf

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: IBSA generates revenue through the development, manufacturing, and commercialization of pharmaceutical products across 10 therapy areas. Products are distributed through the company's own subsidiaries and commercial partners in 90+ countries.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

IBSA Germany develops, manufactures, and commercializes pharmaceutical products across 10 therapy areas including reproductive medicine, endocrinology, pain and inflammation, osteoarticular, aesthetic medicine, dermatology, uro-gynecology, cardiometabolic medicine, respiratory, and consumer health. As the German subsidiary of IBSA Group, it serves as the commercial entry point for IBSA's diversified portfolio in the German market, operating from Düsseldorf.

Product overview

IBSA Germany is the German subsidiary of IBSA (Institut Biochimique SA), a multinational Swiss pharmaceutical company founded in 1945 in Lugano. The company operates as a diversified pharmaceutical portfolio spanning 10 therapy areas: Reproduktionsmedizin (Reproductive Medicine), Endokrinologie (Endocrinology), Schmerzen und Entzündungen (Pain and Inflammation), Knochen und Gelenkapparat (Bone and Joint), Ästhetische Medizin (Aesthetic Medicine), Uro-Gynäkologie (Uro-Gynecology), Dermatologie (Dermatology), Kardiometabolische Medizin (Cardiometabolic Medicine), Atemwege (Respiratory), and Consumer Health. Products are distributed across 90 countries with 20 subsidiaries globally. IBSA Germany is located in Düsseldorf and serves the German market with prescription and consumer health pharmaceuticals.

Differentiator

Problem solved

Functional benefit

Products and services

• Reproductive Medicine (Reproduktionsmedizin) Pharmaceutical products for reproductive medicine, including fertility treatments and reproductive health therapies for patients seeking assisted reproduction.
• Endocrinology (Endokrinologie) Pharmaceutical products for endocrine disorders, including hormone replacement therapies and treatments for thyroid and metabolic conditions.
• Pain and Inflammation (Schmerzen und Entzündungen) Pharmaceutical products for pain management and inflammatory conditions, providing anti-inflammatory treatments and pain relief therapies.
• Bone and Joint (Knochen und Gelenkapparat) Pharmaceutical products for osteoarticular conditions, including treatments for osteoporosis and joint disorders.
• Aesthetic Medicine (Ästhetische Medizin) Pharmaceutical products for aesthetic and cosmetic medicine applications, including dermal fillers and anti-aging treatments.
• Uro-Gynecology (Uro-Gynäkologie) Pharmaceutical products for urological and gynecological conditions.
• Dermatology (Dermatologie) Pharmaceutical products for skin conditions and dermatological treatments.
• Cardiometabolic Medicine (Kardiometabolische Medizin) Pharmaceutical products for cardiometabolic disorders including diabetes and cardiovascular conditions.
• Respiratory (Atemwege) Pharmaceutical products for respiratory conditions affecting the airways.
• Consumer Health Over-the-counter pharmaceutical products for consumer health and wellness.

Quantifiable outcome

• Products distributed in 90 countries across 5 continents

Segments9 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• IBSA GroupcoreOthersIBSA Germany (IBSA Pharma GmbH) is a subsidiary of IBSA Group (Institut Biochimique SA), a Swiss multinational pharmaceutical company founded in 1945 in Lugano. IBSA Group provides strategic direction, brand identity, and corporate governance to its 20 global subsidiaries including IBSA Germany.

Scale indicators4 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• Ferring Pharmaceuticals: Switzerland-based multinational pharmaceutical company with a strong reproductive medicine and women's health portfolio, directly overlapping with IBSA Germany's primary therapeutic segment.
• Galderma: Global dermatology and aesthetic medicine company, directly comparable to IBSA Germany's aesthetic medicine and dermatology therapy areas.
• Merz Therapeutics: German pharmaceutical and aesthetics company with products in aesthetic medicine, dermatology, and pain — directly aligned with IBSA Germany's aesthetic and pain/inflammation franchises.
• Theramex: UK-based global specialty pharmaceutical company dedicated to women's health including reproductive medicine and menopause — directly comparable to IBSA Germany's reproductive and endocrine franchises.
• Gedeon Richter: Hungarian-headquartered European pharma with strong positions in women's health, reproductive medicine, and endocrinology — a closely comparable European mid-cap peer in IBSA Germany's core therapy areas.
• Organon: Global pharmaceutical company spun out of Merck focused on women's health, reproductive medicine, and biosimilars — directly comparable to IBSA Germany's primary reproductive medicine focus.
• Stada Arzneimittel: German-headquartered pharmaceutical company with broad portfolio across multiple therapy areas including endocrinology and consumer health, comparable in horizontal portfolio strategy to IBSA Germany.
• Grünenthal: Germany-based mid-sized pharmaceutical company with a strong focus on pain and inflammation — a therapy area IBSA Germany explicitly serves — making it a directly comparable mid-cap German pharma peer.

Broad incumbents

• Bayer Pharma: German-headquartered global pharmaceutical giant with women's health, cardiology, and consumer health portfolios — overlapping with IBSA Germany's cardiometabolic, uro-gynecology, and consumer health segments as a broad incumbent.
• Merck KGaA: Germany-headquartered global science and technology company with a healthcare division covering endocrinology, fertility, and oncology — a broad incumbent peer in the German pharma landscape.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/ibsa-germany

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IBSA Germany